Drug Research and Development Experts form Michigan CMC Alliance
(March 31, 2009; Kalamazoo, MI)-Several Michigan companies have formed a strategic alliance centered around pharmaceutical chemistry, manufacturing and control development (CMC), aptly called the Michigan CMC Alliance. This alliance is comprised of contract service providers, each an expert in a distinct component in the drug development spectrum, from preclinical to clinical phases and regulatory submission/approval.
Member organizations each have a firm foundation of experience and expertise within the pharmaceutical industry along with a scientific infrastructure to deliver cost-effective, compliant results. The ability to leverage the intellectual capital resident within each organization is a distinct advantage to those in need of pharmaceutical CMC resources and expert strategies for comprehensive drug development.
The Michigan CMC Alliance brings together the forces of:
· Ash Stevens, Inc.: GMP AP development and manufacturing
· BioSTAT Consultants:Statistical services: design and analysis
· Eurofins AvTech Laboratories, Inc.:GMP and GLP analytical services
· Global Clinical Connections, LLC: Clinical supplies management
· Pharmaceutical Development Consulting, LLC: Formulation Development & Project Management
· PharmaMed Resources, LLC: Quality assurance
· ProReg Resources, LLC:Regulatory consulting services
· Velesco Pharmaceutical Services: Formulation, analytical development and GMP manufacturing
“There is an abundance of pharma industry knowledge within Michigan; niche experts in each phase or components necessary to propel a drug forward through the development process. It seemed a natural fit to combine our forces in a strategic alliance,” stated Bill Pfund, a Director at Eurofins AvTech Laboratories. “Each company shares a common mission and vision along with a dedication to delivering quality, on-time results with the highest degree of scientific integrity.”
Additional information on the Michigan CMC Alliance can be found at www.micmcalliance.com or by contacting 269-267-7290.
About Michigan CMC Alliance
Michigan CMC Alliance’s mission is to support the growth and success of life science companies everywhere by providing CMC resources and expert strategies to drug development, as well as, education on the complexities of the CMC development process. Utilizing years of experience and a complete understanding of the intricate drug development process, our member companies partner with clients and each other to deliver compliant, effective solutions that drive projects to success, on-time and within budget.
About Eurofins AvTech Laboratories
Eurofins AvTech is an analytical contract research organization (CRO) serving the pharmaceutical industry since 1990. AvTech offers comprehensive analytical support for all stages of drug discovery and development from early ADME studies of drug candidates, to stability and release testing of the finished product. Eurofins AvTech places special emphasis on the development, validation, and routine performance of GMP and GLP compliant methods.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
